Still, results should be carefully generalized to cases of background kidney dysfunction or when using drugs with narrow therapeutic index
10.1111/jnc.12686 J
*Correspondence: Yi Hua, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Peptides have become the beauty world's latest buzzword and one of the biggest skincare trends, with dermatologists and skincare gurus highlighting their anti-aging benefits across social media
Pancreatic Health (Amylase and Lipase) Though very rare, inflammation of the pancreas (pancreatitis) is a noted potential risk for this class of medication
GLP-1s and SGLT2s: The New Power Players in Diabetes Care By 2024, more Medicare patients with T2D are sticking with GLP-1 or SGLT2 therapies as their sole treatment, doubling since 2020